MegaPro Biomedical Co (ROCO:6827) Total Liabilities: NT$16.28 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6827 MegaPro Biomedical Co Ltd ROCO:6827
33 GF Score
Price NT$10.70
View Full Analysis

What is MegaPro Biomedical Co Total Liabilities?

MegaPro Biomedical Co ROCO:6827 -2.28% 33 Total Liabilities is NT$16.28 Mil as of Dec. 2025. GuruFocus rates ROCO:6827 with a GF Score™ of 33/100.

MegaPro Biomedical Co's Total Liabilities for the quarter that ended in Dec. 2025 was NT$16.28 Mil.

MegaPro Biomedical Co's quarterly Total Liabilities increased from Dec. 2024 (NT$19.96 Mil) to Jun. 2025 (NT$29.45 Mil) but then declined from Jun. 2025 (NT$29.45 Mil) to Dec. 2025 (NT$16.28 Mil).

MegaPro Biomedical Co's annual Total Liabilities declined from Dec. 2023 (NT$25.51 Mil) to Dec. 2024 (NT$19.96 Mil) and declined from Dec. 2024 (NT$19.96 Mil) to Dec. 2025 (NT$16.28 Mil).

MegaPro Biomedical Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for MegaPro Biomedical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MegaPro Biomedical Co Total Liabilities Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 26.77 28.34 25.51 19.96 16.28

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.51 22.29 19.96 29.45 16.28
ROCO:6827
33GF Score
MegaPro Biomedical Co Ltd ROCO:6827
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MegaPro Biomedical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MegaPro Biomedical Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=15.938+(0+0.341
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=16.28

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=278.917-262.638
=16.28

MegaPro Biomedical Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=15.938+(0+0.341
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=16.28

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=278.917-262.638
=16.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$16.28 Mil mean?
MegaPro Biomedical Co (ROCO:6827) has a Total Liabilities of NT$16.28 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MegaPro Biomedical Co and its competitors.
Is MegaPro Biomedical Co's Total Liabilities too high?
MegaPro Biomedical Co's current Total Liabilities is NT$16.28 Mil. Overall, MegaPro Biomedical Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does MegaPro Biomedical Co's Total Liabilities compare to VRTX and REGN?
MegaPro Biomedical Co's Total Liabilities of NT$16.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MegaPro Biomedical Co and its competitors. MegaPro Biomedical Co's current Total Liabilities is NT$16.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MegaPro Biomedical Co stock overvalued right now?
MegaPro Biomedical Co (ROCO:6827) has a current Total Liabilities of NT$16.28 Mil. The current Total Liabilities is NT$16.28 Mil. MegaPro Biomedical Co's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For MegaPro Biomedical Co (ROCO:6827), the current Total Liabilities is NT$16.28 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MegaPro Biomedical Co Business Description

Address No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
33GF Score

Get the complete analysis for ROCO:6827

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.70
Price